Evidence map›Paper›PMID 31054079›Full record

ArticleJournal of physiology and biochemistry2019

LPS-squalene interaction on D-galactose intestinal absorption.

Ma José Felices, Sara Escusol, Roberto Martinez-Beamonte, Sonia Gascón, Cristina Barranquero, Cristina Sanchez-de-Diego, Jesús Osada, Ma Jesús Rodríguez-Yoldi

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of physiology and biochemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Ma José FelicesDepartment of Pharmacology and Physiology, University of Zaragoza, 50013, Zaragoza, Spain.
Sara EscusolDepartment of Pharmacology and Physiology, University of Zaragoza, 50013, Zaragoza, Spain.
Roberto Martinez-BeamonteDepartment of Biochemistry, Molecular and Cellular Biology, Veterinary Faculty, University of Zaragoza, 50013, Zaragoza, Spain.
Sonia GascónDepartment of Pharmacology and Physiology, University of Zaragoza, 50013, Zaragoza, Spain.
Cristina BarranqueroDepartment of Biochemistry, Molecular and Cellular Biology, Veterinary Faculty, University of Zaragoza, 50013, Zaragoza, Spain.
Cristina Sanchez-de-DiegoDepartment Physiological Sciences II, University of Barcelona, Barcelona, Spain.
Jesús OsadaDepartment of Biochemistry, Molecular and Cellular Biology, Veterinary Faculty, University of Zaragoza, 50013, Zaragoza, Spain.
Ma Jesús Rodríguez-YoldiDepartment of Pharmacology and Physiology, University of Zaragoza, 50013, Zaragoza, Spain. mjrodyol@unizar.es.
Universidad de Zaragoza · ESInstituto de Salud Carlos III · ESUniversitat de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The dynamic and complex interactions between enteric pathogens and the intestinal epithelium often lead to disturbances in the intestinal barrier, altered fluid, electrolyte, and nutrient transport and can produce an inflammatory response. Lipopolysaccharide (LPS) is a complex polymer forming part of the outer membrane of Gram-negative bacteria. On the other hand, squalene is a triterpene present in high levels in the extra-virgin olive oil that has beneficial effects against several diseases and it has also anti-oxidant and anti-inflammatory properties. The aim of this work was to study whether the squalene could eliminate the LPS effect on D-galactose intestinal absorption in rabbits and Caco-2 cells. The results have shown that squalene reduced the effects of LPS on sugar absorption. High LPS doses increased D-galactose uptake through via paracellular but also decreased the active sugar transport because the SGLT1 levels were diminished. However, the endotoxin effect on the paracellular way seemed to be more important than on the transcellular route. At the same time, an increased in RELM-β expression was observed. This event could be related to inflammation and cause a decrease in SGLT1 levels. In addition, MLCK protein is also increased by LPS which could lead to an increase in sugar transport through tight junctions. At low doses, the LPS could inhibit SGLT1 intrinsic activity. Bioinformatic studies by docking confirm the interaction between LPS-squalene as well as occur through MLCK and SGLT-1 proteins.

Indexed as

Intestinal MucosaAnimalsBiological TransportCaco-2 CellsGalactoseHumansIntestinal AbsorptionLipopolysaccharidesMyosin-Light-Chain KinaseRabbitsSodium-Glucose Transporter 1SqualeneGalactoseLipopolysaccharidesMyosin-Light-Chain KinaseSodium-Glucose Transporter 1SqualeneIntestinal absorptionLPSMLCKRELM-βSGLT1Squalene

Identifiers

PMID31054079
OpenAlexW2943044570

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.